IceCure Medical Ltd.
corporate_fare Company Profile
IceCure Medical Ltd. (NASDAQ:ICCM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 45 items for ICCM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ICCM spans 6-K, F-3.
Recent high-impact activity:
- AMA Rejects Permanent CPT Code for IceCure's Breast Cryoablation — Reimbursement Stays Temporary
- IceCure Wins China Approval for ProSense Cryoablation System
- IceCure Secures NMPA Approval to Market ProSense® in China
- IceCure Inks Exclusive Netherlands Distribution Deal as THERMAC Trial Advances to Phase III
- IceCure Delivers 45% Revenue Growth but Going Concern Warning Lingers; Class Action Seeks $133.6M
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 52,159 shares in ICCM as of the September 30, 2026 settlement, a 49.2% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 9, 2026, 22.2% of ICCM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for ICCM, detected from its recent SEC filings · based on capital-structure filings through 2026-07-02.
New At-The-Market (ATM) Program · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
ICCM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.